Nab-paclitaxel (Nab-P) in patients (pts) with HER2-ve advanced breast cancer (ABC): A focus on the elderly-Preliminary results of the GIM-13 AMBRA study.

被引：0
|
作者：
Mustacchi, Giorgio
Pronzato, Paolo
D'Alonzo, Alessia
Mocerino, Carmela
Romagnoli, Emanuela
Garrone, Ornella
Blasi, Livio
De Laurentiis, Michelino
Michelotti, Andrea
Bologna, Alessandra
Giordano, Monica
Turletti, Anna
Montemurro, Filippo
De Placido, Sabino
Natoli, Clara
Taverniti, Cristiana
Biganzoli, Laura
Meattini, Icro
Marchetti, Paolo
Cazzaniga, Marina Elena
机构：
[1] Univ Trieste, Trieste, Italy
[2] San Martino IST Ist Naz Ric Cancr, Genoa, Italy
[3] Osped Policlin San Martino Oncol Med, Genoa, Italy
[4] AORN A Cardarelli Hosp, Naples, Italy
[5] Osped Macerata, UOC Oncol, Macerata, Italy
[6] S Croce & Carle Teaching Hosp, Med Oncol, Cuneo, Italy
[7] Fdn San Raffaele Giglio, Palerio, Italy
[8] Fdn Pascale, Breast Unit, Naples, Italy
[9] Azienda Osped Univ Pisana, Oncol Unit 1, Pisa, Italy
[10] IRCCS Arcispedale Santa Maria Nuova, Reggio Emilia, Italy
[11] Santa Anna Hosp, Como, Italy
[12] ASLTO1 Osped Martini, Med Oncol, Turin, Italy
[13] Invest Clin Oncol Candiolo Canc Inst FPO IRCCS, Candiolo, Italy
[14] Univ Naples Federico II, Naples, Italy
[15] Univ G dAnnunzio, Dept Expt & Clin Sci, Chieti, Italy
[16] AOU Citta Salute & Sci, Med Oncol, Turin, Italy
[17] Hosp Prato, Sandro Pitigliani Med Oncol Dept, Prato, Italy
[18] Univ Florence, Florence, Italy
[19] Sapienza Univ Rome, S Andrea Hosp, Rome, Italy
[20] Hosp San Gerardo, Oncol Unit, Monza, MB, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e13078
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13078
引用
收藏
页数：1
相关论文
共 50 条
  • [21] ABOUND.70+: Safety and efficacy of nab-paclitaxel/carboplatin (nab-P/C) in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC).
    Langer, Corey J.
    Anderson, Eric C.
    Jotte, Robert M.
    Goldman, Jonathan Wade
    Haggstrom, Daniel Ernest
    Socoteanu, Matei Paul
    Smith, David A.
    Dakhil, Christopher
    Konduri, Kartik
    Kim, Edward S.
    Ong, Teng Jin
    Sanford, Alexandra
    Amiri, Katayoun
    Weiss, Jared
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [22] A phase study of two different schedules of nab-paclitaxel (Nab-p) with ascending doses of vandetanib (V) in patients (pts) with advanced solid tumors.
    El-Khoueiry, A. B.
    Iqbal, S.
    Lenz, H.
    Roman, L.
    Gitlitz, B. J.
    Yang, D.
    Cole, S.
    Shriki, J.
    Hughlett, C.
    Garcia, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [23] Quality of life (QoL) in elderly patients (pts) with advanced NSCLC treated with nab-paclitaxel (nab-P) plus carboplatin (C): Interim results from the ABOUND. 70+study
    Weiss, J.
    Kim, E.
    Amiri, K. I.
    Anderson, E.
    Dakhil, S.
    Haggstrom, D.
    Jotte, R.
    Konduri, K.
    Modiano, M.
    Ong, T. J.
    Sanford, A.
    Smith, D.
    Socoteanu, M.
    Goldman, J.
    Langer, C.
    ANNALS OF ONCOLOGY, 2016, 27
  • [24] nab-Paclitaxel (nab-P) plus gemcitabine (G) for patients (Pts) with locally advanced pancreatic cancer (LAPC): Interim efficacy and safety results from the Phase 2 LAPACT Trial
    Philip, P. A.
    Lacy, J.
    Portales, F.
    Sobrero, A.
    Pazo-Cid, R.
    Manzano Mozo, J. L.
    Kim, E. S.
    Dowden, S.
    Zakari, A.
    Borg, C.
    Terrebonne, E.
    Rivera Herrero, F.
    Shiansong Li, J.
    Ong, T. J.
    Nydam, T.
    Hammel, P.
    ANNALS OF ONCOLOGY, 2017, 28
  • [25] nab-Paclitaxel plus carboplatin (nab-P/C) in advanced non-small cell lung cancer (NSCLC): outcomes in elderly patients (pts) with squamous (SCC) histology
    Gridelli, C.
    Ko, A.
    O'Brien, M.
    Ong, T. J.
    Socinskis, M. A.
    Postmus, P. E.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S154 - S155
  • [26] Subgroup analysis of IMpassion130: Atezolizumab plus nab-paclitaxel (nab-P) in patients (pts) with advanced triple-negative breast cancer (TNBC) in Asian countries
    Iwata, H.
    Im, S-A.
    Sohn, J.
    Jung, K. H.
    Im, Y-H.
    Lee, K. S.
    Inoue, K.
    Tamura, K.
    Wong, A.
    Emens, L. A.
    Barrios, C. H.
    Adams, S.
    Schneeweiss, A.
    Dieras, V.
    Winer, E. P.
    Chui, S. Y.
    Henschel, V.
    Rugo, H. S.
    Loi, S.
    Schmid, P.
    ANNALS OF ONCOLOGY, 2019, 30
  • [27] Real-world efficacy and safety outcomes of nab-paclitaxel (nab-P) in patients (pts) with metastatic breast cancer (MBC): Results from a US health insurance database
    Patt, Debra A.
    Liang, Caihua
    Li, Ling
    Ko, Amy
    Fraser, Cindy Duval
    Corzo, Deyanira
    Enger, Cheryl
    CANCER RESEARCH, 2015, 75
  • [28] Safety and efficacy of nab-paclitaxel (nab-P) in patients (pts) with metastatic breast cancer (MBC): Real-world results from a US health insurance database.
    Patt, Debra A.
    Liang, Caihua
    Li, Ling
    Ko, Amy
    Fraser, Cindy Duval
    Corzo, Deyanira
    Enger, Cheryl
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [29] Tumor burden reduction between primary and metastatic sites in advanced pancreatic cancer patients (pts) undergoing chemotherapy with nab-paclitaxel (Nab-P) and gemcitabine (Gem)
    Ventriglia, J.
    Laterza, M. M.
    Savastano, B.
    Petrillo, A.
    Tirino, G.
    Diana, A.
    Troiani, T.
    Ciardiello, F.
    De Vita, F.
    ANNALS OF ONCOLOGY, 2015, 26 : 101 - 102
  • [30] Activity, efficacy, and safety of nab-paclitaxel (Nab-P) and gemcitabine (G) in heavily pretreated advanced pancreatic cancer (APDAC) patients (pts): A multicenter retrospective analysis
    Febbraro, Antonio
    Zaniboni, Alberto
    Zagonel, Vittorina
    Di Costanzo, Francesco
    Malorino, Luigi
    Bertocchi, Paola
    Bergamo, Francesca
    Glommonl, Ellsa
    Giordano, Guida
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345